Tianyin Pharmaceutical Inc Co  

(Public, NYSEMKT:TPI)   Watch this stock  
Find more results for TPI
0.636
+0.015 (2.35%)
Feb 26 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.56 - 0.64
52 week 0.43 - 1.37
Open 0.59
Vol / Avg. 33,509.00/108,640.00
Mkt cap 18.73M
P/E     -
Div/yield     -
EPS -0.04
Shares 29.43M
Beta 1.63
Inst. own 6%
Dec 24, 2014
Q1 2015 Tianyin Pharmaceutical Co Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 10.04% -1.74%
Operating margin 14.59% 5.77%
EBITD margin - 11.32%
Return on average assets 3.66% -0.74%
Return on average equity 4.08% -0.66%
Employees 1,000 -
CDP Score - -

Address

23rd Floor, Unionsun Yangkuo Plaza, No. 2, 3rd block, South Renmin Road
CHENGDU, SIC 610041
China
+86-28-82002232 (Phone)
+86-28-85516676 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Tianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company�s indirect wholly owned subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd., it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in China. As of June 30, 2013, the Company is manufacturing a range of 58 products approved by the China Food and Drug Administration (CFDA), 24 of which are listed in the National Medical Reimbursement List (NMRL) and 10 are listed in the Essential Drug List (EDL) of the China. The Company�s medicines are used in the therapeutic areas of internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, dermatology, pediatrics, gastroenterology and orthopedics. The Company markets its products through regional distributors, as well as directly to the hospitals, clinics and pharmacies.

Officers and directors

Guoqing Jiang Chairman of the Board, President, Chief Executive Officer, Acting Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Tao Yang Chief Operating Officer
Age: 45
Bio & Compensation  - Reuters
Xintao You Chief Technology Officer
Bio & Compensation  - Reuters
Jianping Hou Ph.D. Independent Director
Age: 52
Bio & Compensation  - Reuters
Zhan Yong Independent Director
Bio & Compensation  - Reuters
Zunjian Zhang Ph.D. Independent Director
Age: 53
Bio & Compensation  - Reuters